Exicure, Inc. Files 8-K: Financial Statements and Exhibits
Ticker: XCUR · Form: 8-K · Filed: Sep 18, 2024 · CIK: 1698530
| Field | Detail |
|---|---|
| Company | Exicure, Inc. (XCUR) |
| Form Type | 8-K |
| Filed Date | Sep 18, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, sec-filing
TL;DR
EXICURE FILES 8-K WITH FINANCIALS AND EXHIBITS - ROUTINE FILING.
AI Summary
On September 18, 2024, Exicure, Inc. filed an 8-K report. The filing primarily serves as a notification of the company's financial statements and exhibits. No specific material events or financial figures were detailed in the provided excerpt, indicating a routine filing.
Why It Matters
This filing indicates that Exicure, Inc. is providing necessary financial documentation to the SEC, which is standard for public companies and important for investor transparency.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial statements and exhibits, not indicating any new material events or risks.
Key Players & Entities
- Exicure, Inc. (company) — Registrant
- 0001698530-24-000106 (document_id) — Accession Number
- September 18, 2024 (date) — Date of Report
- 2430 N. Halsted St. Chicago, IL 60614 (address) — Principal Executive Offices
- 001-39011 (company_id) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing by Exicure, Inc.?
The primary purpose of this 8-K filing by Exicure, Inc. is to disclose financial statements and exhibits as of September 18, 2024.
What is Exicure, Inc.'s SEC file number?
Exicure, Inc.'s SEC file number is 001-39011.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 18, 2024.
What is Exicure, Inc.'s principal executive office address?
Exicure, Inc.'s principal executive office is located at 2430 N. Halsted St. Chicago, IL 60614.
What is the accession number for this filing?
The accession number for this filing is 0001698530-24-000106.
Filing Stats: 628 words · 3 min read · ~2 pages · Grade level 11.8 · Accepted 2024-09-18 16:18:06
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share XCUR The Nasdaq Stock Market
Filing Documents
- xcur-20240918.htm (8-K) — 27KB
- a8k91824-exhibit991.htm (EX-99.1) — 8KB
- exicureimage1a10.gif (GRAPHIC) — 3KB
- 0001698530-24-000106.txt ( ) — 162KB
- xcur-20240918.xsd (EX-101.SCH) — 2KB
- xcur-20240918_lab.xml (EX-101.LAB) — 21KB
- xcur-20240918_pre.xml (EX-101.PRE) — 12KB
- xcur-20240918_htm.xml (XML) — 3KB
01 Other Regulation FD Disclosure
Item 7.01 Other Regulation FD Disclosure On September 18, 2024, Exicure, Inc. (the " Company ") issued a press release noting it received notice that the Nasdaq Hearings Panel granted an extension to continue the Company's listing subject to the Company evidencing compliance with all applicable criteria for continued listing by November 14, 2024. That press release is attached hereto as Exhibit 99.1. Forward Looking Statement. This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. There can be no assurance regarding our ability to comply with the Panel's decision and the applicable listing criteria by the deadline or thereafter. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual outcomes to differ materially from the outcomes expressed or implied by this report. Such risks include, among others, the possibility we will not be able to cure existing listing deficiencies, the possibility of additional deficiencies, the risk that the Company may not adequately comply with the terms of the Panel's decision, and the risk that Nasdaq will ultimately delist the Company's common stock. All such factors are difficult to predict and may be beyond the Company's control. The Company undertakes no obligation and does not intend to update or revise any forward-looking statements contained herein, except as required by law or regulation. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated September 18, 2024 104 Cover Page Interactive Data File (Embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 18, 2024 EXICURE, INC. (registrant) By: /s/ Paul Kang Paul Kang Chief Executive Officer